The clinical effect of simiao pills has been highly praised by experts. Zixin pharmaceutical co., ltd. has joined the gout alliance
The first gout peak BBS in the guangdong-hong kong-macao greater bay area was held in shenzhen on dec 15. At the meeting, led by shenzhen hospital of traditional Chinese medicine, 45 hospitals from 11 cities in the guangdong-hong kong-macao greater bay area jointly established the "anti-gout alliance of the guangdong-hong kong-macao greater bay area traditional Chinese medicine clinical inheritance and innovation research center", which will be committed to carry out all-round research on gout in the clinical inheritance and innovation of traditional Chinese medicine, and benefit the majority of patients. Simiao pills, the classic prescription of zixin pharmaceutical, have significant curative effect in the treatment of gout. For many years, the company has been committed to the basic experimental research and clinical experimental research of simiao pills in gout field. At the conference, zixin pharmaceutical was recognized for its contribution in the gout field. As the only three pharmaceutical enterprises except major hospitals, the company officially joined the gout alliance of the traditional Chinese medicine clinical inheritance and innovation research center in the guangdong-hong kong-macao bay area, and became the vice chairman.
Gout is a common chronic inflammatory joint disease, which is a group of metabolic diseases caused by purine metabolic disorder/uric acid excretion disorders. The incidence of gout is on the rise year by year due to the changes in people's life, diet and other factors, while the severity of arthritis in patients and the diversified complications make gout a major problem troubling human health.
Data from the 2017 China gout status report white paper shows that the number of hyperuricemia patients in China has reached 170 million, among which gout patients are more than 80 million, and the annual growth rate is increasing rapidly at 9.7%. The number of people with gout is expected to reach 100 million by 2020.
Nowadays gout has become the second largest metabolic disease after diabetes in China, which is a health warning that cannot be ignored. High incidence of gout, high disability rate, but awareness rate, control rate, cure rate is very low. At present, the treatment of gout by western medicine is mainly aimed at anti-inflammatory, analgesic and reducing the level of uric acid in blood.
During the assembly, the shenzhen consortium of hospital director of rheumatism, gout professor jian-yong zhang, chairman of the preparatory work is the first report union, and said: "a large bay area of guangdong traditional Chinese medicine clinical inheritance innovation research center of resistance to the establishment of gout alliance to jointly promote the gout YiJiaoYan integrated level and service capabilities, joint research and explore the expert inside course of study in clinical inheritance and innovation of traditional Chinese medicine gout comprehensive study, members will also be fully cooperation, further study of the development of traditional Chinese medicine treatment of gout."
The research and innovation of gout drugs are still on the way. During the conference, experts attending the conference expressed their opinions on the treatment of gout and delivered related topic speeches. Professor jiang quan, director of rheumatology branch of the Chinese association of traditional Chinese medicine and the rheumatology department of guang 'anmen hospital, said that at present the western medicine field can treat gout drugs, mainly including non-steroidal anti-inflammatory drugs, colchicine, glucocorticoids and so on. However, the clinical practice has proved that although the above mentioned drugs can effectively control the development of the disease, the side effects brought by them still cannot be ignored. In recent years, with the deepening of TCM research in the field of gout prevention and treatment, the effect is also very obvious.
In this regard, professor jiang quan made a detailed sharing on the past and present life of the classic fang simiao pill. In the qing dynasty, "four wonderful pills" in "chengjiefeng" was a prescription with high frequency in clinical reports of gout. This square is by yuan zhenheng "Dan xi xin fa" 2 wonderful pill (atractylodes atractylodes, huang bai) add ox knee, coix kernel and become. Atractylodes atractylodes in the square bitter temperature and can dry wet; Cypress bitter cold, into the next coke and remove dampness-heat toxin; Radix cyathulae invigorates blood circulation and dissipates blood stasis to clear collaterals, and can strengthen muscles and bones of liver and kidney. Coix seed dispels dampness and heat and benefits muscles and collaterals. The combination of four drugs can clear away heat and detoxify, reduce swelling by clearing damp, remove blood stasis and relieve pain, which is just targeted at the basic pathogenesis characteristics of gout arthritis in the acute attack period, so it is mostly used as the basic prescription for gout. Professor jiang quan said that simiao pill, as the first classic prescription for treating damp-heat paralysis, has shown good efficacy in both the acute phase of gout and the chronic phase of uric acid lowering, with few side effects, which can effectively avoid the problem of large side effects of western medicine and is not suitable for long-term use.
It is understood that simiao pill is the exclusive product of jilin zixin pharmaceutical co., LTD., the national traditional Chinese medicine protected variety, and the national health insurance class b product. Simiao pill is a pure traditional Chinese medicine preparation, which is not only included in the recommended medication of guidelines for the combined diagnosis and treatment of rheumatoid arthritis, guidelines for the clinical application of Chinese patent medicine rheumatism, guidelines for the diagnosis and treatment of common diseases in the department of peripheral blood vessels (2015), etc. At the same time, it is included in the textbooks of traditional Chinese medicine colleges and universities, rheumatism sub-volume of clinical application guide of Chinese patent medicine, complete complete clinical application of Chinese patent medicine for rheumatic joint disease and other related books. At the same time, it was selected into the 2018 new edition of national essential drugs catalogue in November this year. After entering the list of basic drugs, it will be widely used in hospitals at all levels, and more patients will benefit from it.
As the one of only three join the alliance of pharmaceutical enterprises, purple xin pharmaceutical industry, said the company for a long time with hospitals, universities and society experts such as teamwork, on four wonderful pill gout the basis of experimental study and clinical study, promote production, joint research, common development, four wonderful pill is increasingly toward the way of evidence-based medicine. After joining the anti-gout alliance, the company will adhere to the research and promotion of simiao pills, so that more patients get rid of the pain of gout, and contribute to the promotion of people's health.